APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nootropic Food Ingredients

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nootropic Food Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

7 January 2026194 pages

Choose your research edition.

Industry ResearchNootropic Food Ingredients Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Nootropic Food Ingredients Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Nootropic Food Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nootropic Food Ingredients Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Nootropic Food Ingredients Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Nootropic Food Ingredients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nootropic Food Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nootropic Food Ingredients include Lonza Group, DSM Firmenich, Glanbia Nutritionals, Kerry Group, Ingredion Inc, Cargill Inc, Indena S.p.A, Sabinsa Corporation and Balchem Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nootropic Food Ingredients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nootropic Food Ingredients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nootropic Food Ingredients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nootropic Food Ingredients market size, projected growth trends, production technologies, key applications, and end-use industries.

Nootropic Food Ingredients Segment by Company

Lonza Group

DSM Firmenich

Glanbia Nutritionals

Kerry Group

Ingredion Inc

Cargill Inc

Indena S.p.A

Sabinsa Corporation

Balchem Corporation

Givaudan

Arla Food Ingredients

PLT Health Solutions

Natreon

Kyowa Hakko Bio Co., Ltd

Archer Daniels Midland

BASF SE

Kemin Corporation

Ixoreal Biomed

Beijing Gingko Group

Wuxi Cima Science Co., Ltd.

Nootropic Food Ingredients Segment by Type

Amino Acids and Derivatives

Botanical Extracts

Vitamins and Minerals

Synthetic Nootropis

Others

Nootropic Food Ingredients Segment by Application

Dietary Supplements

Functional Food and Beverages

Sport Nutrition

Clinical and Medical Nutrition

Others

Nootropic Food Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nootropic Food Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nootropic Food Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nootropic Food Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nootropic Food Ingredients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nootropic Food Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nootropic Food Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nootropic Food Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nootropic Food Ingredients Industry Trends Table 2. Nootropic Food Ingredients Industry Drivers Table 3. Nootropic Food Ingredients Industry Opportunities and Challenges Table 4. Nootropic Food Ingredients Industry Restraints Table 5. Global Nootropic Food Ingredients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nootropic Food Ingredients Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nootropic Food Ingredients Sales by Manufacturers (t) & (2021-2026) Table 8. Global Nootropic Food Ingredients Sales Market Share by Manufacturers Table 9. Global Nootropic Food Ingredients Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Nootropic Food Ingredients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nootropic Food Ingredients Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nootropic Food Ingredients Manufacturers, Product Type & Application Table 13. Global Nootropic Food Ingredients Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nootropic Food Ingredients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Amino Acids and Derivatives Table 17. Major Manufacturers of Botanical Extracts Table 18. Major Manufacturers of Vitamins and Minerals Table 19. Major Manufacturers of Synthetic Nootropis Table 20. Major Manufacturers of Others Table 21. Global Nootropic Food Ingredients Sales by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Nootropic Food Ingredients Sales by Type (2021-2026) & (t) Table 23. Global Nootropic Food Ingredients Sales by Type (2027-2032) & (t) Table 24. Global Nootropic Food Ingredients Sales Market Share by Type (2021-2026) Table 25. Global Nootropic Food Ingredients Sales Market Share by Type (2027-2032) Table 26. Global Nootropic Food Ingredients Revenue by Type 2021 VS 2025 VS 2032 (t) Table 27. Global Nootropic Food Ingredients Revenue by Type (2021-2026) & (t) Table 28. Global Nootropic Food Ingredients Revenue by Type (2027-2032) & (t) Table 29. Global Nootropic Food Ingredients Revenue Market Share by Type (2021-2026) Table 30. Global Nootropic Food Ingredients Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Dietary Supplements Table 32. Major Manufacturers of Functional Food and Beverages Table 33. Major Manufacturers of Sport Nutrition Table 34. Major Manufacturers of Clinical and Medical Nutrition Table 35. Major Manufacturers of Others Table 36. Global Nootropic Food Ingredients Sales by Application 2021 VS 2025 VS 2032 (t) Table 37. Global Nootropic Food Ingredients Sales by Application (2021-2026) & (t) Table 38. Global Nootropic Food Ingredients Sales by Application (2027-2032) & (t) Table 39. Global Nootropic Food Ingredients Sales Market Share by Application (2021-2026) Table 40. Global Nootropic Food Ingredients Sales Market Share by Application (2027-2032) Table 41. Global Nootropic Food Ingredients Revenue by Application 2021 VS 2025 VS 2032 (t) Table 42. Global Nootropic Food Ingredients Revenue by Application (2021-2026) & (t) Table 43. Global Nootropic Food Ingredients Revenue by Application (2027-2032) & (t) Table 44. Global Nootropic Food Ingredients Revenue Market Share by Application (2021-2026) Table 45. Global Nootropic Food Ingredients Revenue Market Share by Application (2027-2032) Table 46. Global Nootropic Food Ingredients Sales by Region: 2021 VS 2025 VS 2032 (t) Table 47. Global Nootropic Food Ingredients Sales by Region (2021-2026) & (t) Table 48. Global Nootropic Food Ingredients Sales Market Share by Region (2021-2026) Table 49. Global Nootropic Food Ingredients Sales Forecasted by Region (2027-2032) & (t) Table 50. Global Nootropic Food Ingredients Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 52. North America Nootropic Food Ingredients Sales by Country (2021-2026) & (t) Table 53. North America Nootropic Food Ingredients Sales by Country (2027-2032) & (t) Table 54. Europe Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 55. Europe Nootropic Food Ingredients Sales by Country (2021-2026) & (t) Table 56. Europe Nootropic Food Ingredients Sales by Country (2027-2032) & (t) Table 57. Asia Pacific Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 58. Asia Pacific Nootropic Food Ingredients Sales by Country (2021-2026) & (t) Table 59. Asia Pacific Nootropic Food Ingredients Sales by Country (2027-2032) & (t) Table 60. South America, Middle East and Africa Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 61. South America, Middle East and Africa Nootropic Food Ingredients Sales by Country (2021-2026) & (t) Table 62. South America, Middle East and Africa Nootropic Food Ingredients Sales by Country (2027-2032) & (t) Table 63. Global Nootropic Food Ingredients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Nootropic Food Ingredients Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Nootropic Food Ingredients Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Nootropic Food Ingredients Revenue Market Share by Region (2021-2026) Table 67. Global Nootropic Food Ingredients Revenue Market Share by Region (2027-2032) Table 68. Lonza Group Company Information Table 69. Lonza Group Business Overview Table 70. Lonza Group Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lonza Group Nootropic Food Ingredients Product Portfolio Table 72. Lonza Group Recent Development Table 73. DSM Firmenich Company Information Table 74. DSM Firmenich Business Overview Table 75. DSM Firmenich Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. DSM Firmenich Nootropic Food Ingredients Product Portfolio Table 77. DSM Firmenich Recent Development Table 78. Glanbia Nutritionals Company Information Table 79. Glanbia Nutritionals Business Overview Table 80. Glanbia Nutritionals Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Glanbia Nutritionals Nootropic Food Ingredients Product Portfolio Table 82. Glanbia Nutritionals Recent Development Table 83. Kerry Group Company Information Table 84. Kerry Group Business Overview Table 85. Kerry Group Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Kerry Group Nootropic Food Ingredients Product Portfolio Table 87. Kerry Group Recent Development Table 88. Ingredion Inc Company Information Table 89. Ingredion Inc Business Overview Table 90. Ingredion Inc Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ingredion Inc Nootropic Food Ingredients Product Portfolio Table 92. Ingredion Inc Recent Development Table 93. Cargill Inc Company Information Table 94. Cargill Inc Business Overview Table 95. Cargill Inc Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Cargill Inc Nootropic Food Ingredients Product Portfolio Table 97. Cargill Inc Recent Development Table 98. Indena S.p.A Company Information Table 99. Indena S.p.A Business Overview Table 100. Indena S.p.A Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Indena S.p.A Nootropic Food Ingredients Product Portfolio Table 102. Indena S.p.A Recent Development Table 103. Sabinsa Corporation Company Information Table 104. Sabinsa Corporation Business Overview Table 105. Sabinsa Corporation Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sabinsa Corporation Nootropic Food Ingredients Product Portfolio Table 107. Sabinsa Corporation Recent Development Table 108. Balchem Corporation Company Information Table 109. Balchem Corporation Business Overview Table 110. Balchem Corporation Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Balchem Corporation Nootropic Food Ingredients Product Portfolio Table 112. Balchem Corporation Recent Development Table 113. Givaudan Company Information Table 114. Givaudan Business Overview Table 115. Givaudan Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Givaudan Nootropic Food Ingredients Product Portfolio Table 117. Givaudan Recent Development Table 118. Arla Food Ingredients Company Information Table 119. Arla Food Ingredients Business Overview Table 120. Arla Food Ingredients Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Arla Food Ingredients Nootropic Food Ingredients Product Portfolio Table 122. Arla Food Ingredients Recent Development Table 123. PLT Health Solutions Company Information Table 124. PLT Health Solutions Business Overview Table 125. PLT Health Solutions Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. PLT Health Solutions Nootropic Food Ingredients Product Portfolio Table 127. PLT Health Solutions Recent Development Table 128. Natreon Company Information Table 129. Natreon Business Overview Table 130. Natreon Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Natreon Nootropic Food Ingredients Product Portfolio Table 132. Natreon Recent Development Table 133. Kyowa Hakko Bio Co., Ltd Company Information Table 134. Kyowa Hakko Bio Co., Ltd Business Overview Table 135. Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Product Portfolio Table 137. Kyowa Hakko Bio Co., Ltd Recent Development Table 138. Archer Daniels Midland Company Information Table 139. Archer Daniels Midland Business Overview Table 140. Archer Daniels Midland Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Archer Daniels Midland Nootropic Food Ingredients Product Portfolio Table 142. Archer Daniels Midland Recent Development Table 143. BASF SE Company Information Table 144. BASF SE Business Overview Table 145. BASF SE Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. BASF SE Nootropic Food Ingredients Product Portfolio Table 147. BASF SE Recent Development Table 148. Kemin Corporation Company Information Table 149. Kemin Corporation Business Overview Table 150. Kemin Corporation Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Kemin Corporation Nootropic Food Ingredients Product Portfolio Table 152. Kemin Corporation Recent Development Table 153. Ixoreal Biomed Company Information Table 154. Ixoreal Biomed Business Overview Table 155. Ixoreal Biomed Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Ixoreal Biomed Nootropic Food Ingredients Product Portfolio Table 157. Ixoreal Biomed Recent Development Table 158. Beijing Gingko Group Company Information Table 159. Beijing Gingko Group Business Overview Table 160. Beijing Gingko Group Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Beijing Gingko Group Nootropic Food Ingredients Product Portfolio Table 162. Beijing Gingko Group Recent Development Table 163. Wuxi Cima Science Co., Ltd. Company Information Table 164. Wuxi Cima Science Co., Ltd. Business Overview Table 165. Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Sales (t), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Product Portfolio Table 167. Wuxi Cima Science Co., Ltd. Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Nootropic Food Ingredients Distributors List Table 171. Nootropic Food Ingredients Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Nootropic Food Ingredients Product Image Figure 2. Global Nootropic Food Ingredients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nootropic Food Ingredients Market Size (2021-2032) & (US$ Million) Figure 4. Global Nootropic Food Ingredients Sales (2021-2032) & (t) Figure 5. Global Nootropic Food Ingredients Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Nootropic Food Ingredients Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Amino Acids and Derivatives Image Figure 9. Botanical Extracts Image Figure 10. Vitamins and Minerals Image Figure 11. Synthetic Nootropis Image Figure 12. Others Image Figure 13. Global Nootropic Food Ingredients Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Nootropic Food Ingredients Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Nootropic Food Ingredients Sales Market Share by Type (2021-2032) Figure 16. Global Nootropic Food Ingredients Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 17. Global Nootropic Food Ingredients Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Nootropic Food Ingredients Revenue Market Share by Type (2021-2032) Figure 19. Dietary Supplements Image Figure 20. Functional Food and Beverages Image Figure 21. Sport Nutrition Image Figure 22. Clinical and Medical Nutrition Image Figure 23. Others Image Figure 24. Global Nootropic Food Ingredients Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Nootropic Food Ingredients Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Nootropic Food Ingredients Sales Market Share by Application (2021-2032) Figure 27. Global Nootropic Food Ingredients Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 28. Global Nootropic Food Ingredients Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Nootropic Food Ingredients Revenue Market Share by Application (2021-2032) Figure 30. North America Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 31. North America Nootropic Food Ingredients Sales Market Share by Country (2021-2032) Figure 32. U.S. Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 33. Canada Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 34. Mexico Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 35. Europe Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 36. Europe Nootropic Food Ingredients Sales Market Share by Country (2021-2032) Figure 37. Germany Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 38. France Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 39. U.K. Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 40. Italy Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 41. Netherlands Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 42. Asia Pacific Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 43. Asia Pacific Nootropic Food Ingredients Sales Market Share by Country (2021-2032) Figure 44. China Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 45. Japan Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 46. South Korea Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 47. Southeast Asia Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 48. India Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 49. Australia Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 50. South America, Middle East and Africa Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 51. South America, Middle East and Africa Nootropic Food Ingredients Sales Market Share by Country (2021-2032) Figure 52. Brazil Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 53. South Africa Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 54. Saudi Arabia Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 55. Turkey Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 56. Argentina Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 57. UAE Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 58. Egypt Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 59. Chile Nootropic Food Ingredients Sales and Growth Rate (2021-2032) & (t) Figure 60. Global Nootropic Food Ingredients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Nootropic Food Ingredients Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Nootropic Food Ingredients Revenue (2021-2032) & (US$ Million) Figure 63. North America Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Nootropic Food Ingredients Revenue (2021-2032) & (US$ Million) Figure 65. Europe Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Nootropic Food Ingredients Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Nootropic Food Ingredients Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Nootropic Food Ingredients Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Nootropic Food Ingredients Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acids and Derivatives
  • Botanical Extracts
  • Vitamins and Minerals
  • Synthetic Nootropis
  • Others
Applications
  • Dietary Supplements
  • Functional Food and Beverages
  • Sport Nutrition
  • Clinical and Medical Nutrition
  • Others
Companies covered
  • Lonza Group
  • DSM Firmenich
  • Glanbia Nutritionals
  • Kerry Group
  • Ingredion Inc
  • Cargill Inc
  • Indena S.p.A
  • Sabinsa Corporation
  • Balchem Corporation
  • Givaudan
  • Arla Food Ingredients
  • PLT Health Solutions
  • Natreon
  • Kyowa Hakko Bio Co., Ltd
  • Archer Daniels Midland
  • BASF SE
  • Kemin Corporation
  • Ixoreal Biomed
  • Beijing Gingko Group
  • Wuxi Cima Science Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nootropic Food Ingredients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nootropic Food Ingredients Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nootropic Food Ingredients Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nootropic Food Ingredients Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nootropic Food Ingredients Market Dynamics
  1. 2.1 Nootropic Food Ingredients Industry Trends
  2. 2.2 Nootropic Food Ingredients Industry Drivers
  3. 2.3 Nootropic Food Ingredients Industry Opportunities and Challenges
  4. 2.4 Nootropic Food Ingredients Industry Restraints
3 Nootropic Food Ingredients Market by Manufacturers
  1. 3.1 Global Nootropic Food Ingredients Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nootropic Food Ingredients Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nootropic Food Ingredients Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nootropic Food Ingredients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nootropic Food Ingredients Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nootropic Food Ingredients Manufacturers, Product Type & Application
  7. 3.7 Global Nootropic Food Ingredients Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nootropic Food Ingredients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nootropic Food Ingredients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nootropic Food Ingredients Tier 1, Tier 2, and Tier 3
4 Nootropic Food Ingredients Market by Type
  1. 4.1 Nootropic Food Ingredients Type Introduction
  2. 4.1.1 Amino Acids and Derivatives
  3. 4.1.2 Botanical Extracts
  4. 4.1.3 Vitamins and Minerals
  5. 4.1.4 Synthetic Nootropis
  6. 4.1.5 Others
  7. 4.2 Global Nootropic Food Ingredients Sales by Type
  8. 4.2.1 Global Nootropic Food Ingredients Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Nootropic Food Ingredients Sales by Type (2021-2032)
  10. 4.2.3 Global Nootropic Food Ingredients Sales Market Share by Type (2021-2032)
  11. 4.3 Global Nootropic Food Ingredients Revenue by Type
  12. 4.3.1 Global Nootropic Food Ingredients Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Nootropic Food Ingredients Revenue by Type (2021-2032)
  14. 4.3.3 Global Nootropic Food Ingredients Revenue Market Share by Type (2021-2032)
5 Nootropic Food Ingredients Market by Application
  1. 5.1 Nootropic Food Ingredients Application Introduction
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Functional Food and Beverages
  4. 5.1.3 Sport Nutrition
  5. 5.1.4 Clinical and Medical Nutrition
  6. 5.1.5 Others
  7. 5.2 Global Nootropic Food Ingredients Sales by Application
  8. 5.2.1 Global Nootropic Food Ingredients Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nootropic Food Ingredients Sales by Application (2021-2032)
  10. 5.2.3 Global Nootropic Food Ingredients Sales Market Share by Application (2021-2032)
  11. 5.3 Global Nootropic Food Ingredients Revenue by Application
  12. 5.3.1 Global Nootropic Food Ingredients Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nootropic Food Ingredients Revenue by Application (2021-2032)
  14. 5.3.3 Global Nootropic Food Ingredients Revenue Market Share by Application (2021-2032)
6 Global Nootropic Food Ingredients Sales by Region
  1. 6.1 Global Nootropic Food Ingredients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nootropic Food Ingredients Sales by Region (2021-2032)
  3. 6.2.1 Global Nootropic Food Ingredients Sales by Region (2021-2026)
  4. 6.2.2 Global Nootropic Food Ingredients Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nootropic Food Ingredients Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nootropic Food Ingredients Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nootropic Food Ingredients Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nootropic Food Ingredients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nootropic Food Ingredients Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nootropic Food Ingredients Revenue by Region
  1. 7.1 Global Nootropic Food Ingredients Revenue by Region
  2. 7.1.1 Global Nootropic Food Ingredients Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nootropic Food Ingredients Revenue by Region (2021-2026)
  4. 7.1.3 Global Nootropic Food Ingredients Revenue by Region (2027-2032)
  5. 7.1.4 Global Nootropic Food Ingredients Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nootropic Food Ingredients Revenue (2021-2032)
  8. 7.2.2 North America Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nootropic Food Ingredients Revenue (2021-2032)
  11. 7.3.2 Europe Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nootropic Food Ingredients Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nootropic Food Ingredients Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nootropic Food Ingredients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza Group
  2. 8.1.1 Lonza Group Company Information
  3. 8.1.2 Lonza Group Business Overview
  4. 8.1.3 Lonza Group Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Group Nootropic Food Ingredients Product Portfolio
  6. 8.1.5 Lonza Group Recent Developments
  7. 8.2 DSM Firmenich
  8. 8.2.1 DSM Firmenich Company Information
  9. 8.2.2 DSM Firmenich Business Overview
  10. 8.2.3 DSM Firmenich Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DSM Firmenich Nootropic Food Ingredients Product Portfolio
  12. 8.2.5 DSM Firmenich Recent Developments
  13. 8.3 Glanbia Nutritionals
  14. 8.3.1 Glanbia Nutritionals Company Information
  15. 8.3.2 Glanbia Nutritionals Business Overview
  16. 8.3.3 Glanbia Nutritionals Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glanbia Nutritionals Nootropic Food Ingredients Product Portfolio
  18. 8.3.5 Glanbia Nutritionals Recent Developments
  19. 8.4 Kerry Group
  20. 8.4.1 Kerry Group Company Information
  21. 8.4.2 Kerry Group Business Overview
  22. 8.4.3 Kerry Group Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kerry Group Nootropic Food Ingredients Product Portfolio
  24. 8.4.5 Kerry Group Recent Developments
  25. 8.5 Ingredion Inc
  26. 8.5.1 Ingredion Inc Company Information
  27. 8.5.2 Ingredion Inc Business Overview
  28. 8.5.3 Ingredion Inc Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ingredion Inc Nootropic Food Ingredients Product Portfolio
  30. 8.5.5 Ingredion Inc Recent Developments
  31. 8.6 Cargill Inc
  32. 8.6.1 Cargill Inc Company Information
  33. 8.6.2 Cargill Inc Business Overview
  34. 8.6.3 Cargill Inc Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cargill Inc Nootropic Food Ingredients Product Portfolio
  36. 8.6.5 Cargill Inc Recent Developments
  37. 8.7 Indena S.p.A
  38. 8.7.1 Indena S.p.A Company Information
  39. 8.7.2 Indena S.p.A Business Overview
  40. 8.7.3 Indena S.p.A Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Indena S.p.A Nootropic Food Ingredients Product Portfolio
  42. 8.7.5 Indena S.p.A Recent Developments
  43. 8.8 Sabinsa Corporation
  44. 8.8.1 Sabinsa Corporation Company Information
  45. 8.8.2 Sabinsa Corporation Business Overview
  46. 8.8.3 Sabinsa Corporation Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sabinsa Corporation Nootropic Food Ingredients Product Portfolio
  48. 8.8.5 Sabinsa Corporation Recent Developments
  49. 8.9 Balchem Corporation
  50. 8.9.1 Balchem Corporation Company Information
  51. 8.9.2 Balchem Corporation Business Overview
  52. 8.9.3 Balchem Corporation Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Balchem Corporation Nootropic Food Ingredients Product Portfolio
  54. 8.9.5 Balchem Corporation Recent Developments
  55. 8.10 Givaudan
  56. 8.10.1 Givaudan Company Information
  57. 8.10.2 Givaudan Business Overview
  58. 8.10.3 Givaudan Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Givaudan Nootropic Food Ingredients Product Portfolio
  60. 8.10.5 Givaudan Recent Developments
  61. 8.11 Arla Food Ingredients
  62. 8.11.1 Arla Food Ingredients Company Information
  63. 8.11.2 Arla Food Ingredients Business Overview
  64. 8.11.3 Arla Food Ingredients Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Arla Food Ingredients Nootropic Food Ingredients Product Portfolio
  66. 8.11.5 Arla Food Ingredients Recent Developments
  67. 8.12 PLT Health Solutions
  68. 8.12.1 PLT Health Solutions Company Information
  69. 8.12.2 PLT Health Solutions Business Overview
  70. 8.12.3 PLT Health Solutions Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PLT Health Solutions Nootropic Food Ingredients Product Portfolio
  72. 8.12.5 PLT Health Solutions Recent Developments
  73. 8.13 Natreon
  74. 8.13.1 Natreon Company Information
  75. 8.13.2 Natreon Business Overview
  76. 8.13.3 Natreon Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Natreon Nootropic Food Ingredients Product Portfolio
  78. 8.13.5 Natreon Recent Developments
  79. 8.14 Kyowa Hakko Bio Co., Ltd
  80. 8.14.1 Kyowa Hakko Bio Co., Ltd Company Information
  81. 8.14.2 Kyowa Hakko Bio Co., Ltd Business Overview
  82. 8.14.3 Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kyowa Hakko Bio Co., Ltd Nootropic Food Ingredients Product Portfolio
  84. 8.14.5 Kyowa Hakko Bio Co., Ltd Recent Developments
  85. 8.15 Archer Daniels Midland
  86. 8.15.1 Archer Daniels Midland Company Information
  87. 8.15.2 Archer Daniels Midland Business Overview
  88. 8.15.3 Archer Daniels Midland Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Archer Daniels Midland Nootropic Food Ingredients Product Portfolio
  90. 8.15.5 Archer Daniels Midland Recent Developments
  91. 8.16 BASF SE
  92. 8.16.1 BASF SE Company Information
  93. 8.16.2 BASF SE Business Overview
  94. 8.16.3 BASF SE Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BASF SE Nootropic Food Ingredients Product Portfolio
  96. 8.16.5 BASF SE Recent Developments
  97. 8.17 Kemin Corporation
  98. 8.17.1 Kemin Corporation Company Information
  99. 8.17.2 Kemin Corporation Business Overview
  100. 8.17.3 Kemin Corporation Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Kemin Corporation Nootropic Food Ingredients Product Portfolio
  102. 8.17.5 Kemin Corporation Recent Developments
  103. 8.18 Ixoreal Biomed
  104. 8.18.1 Ixoreal Biomed Company Information
  105. 8.18.2 Ixoreal Biomed Business Overview
  106. 8.18.3 Ixoreal Biomed Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Ixoreal Biomed Nootropic Food Ingredients Product Portfolio
  108. 8.18.5 Ixoreal Biomed Recent Developments
  109. 8.19 Beijing Gingko Group
  110. 8.19.1 Beijing Gingko Group Company Information
  111. 8.19.2 Beijing Gingko Group Business Overview
  112. 8.19.3 Beijing Gingko Group Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Gingko Group Nootropic Food Ingredients Product Portfolio
  114. 8.19.5 Beijing Gingko Group Recent Developments
  115. 8.20 Wuxi Cima Science Co., Ltd.
  116. 8.20.1 Wuxi Cima Science Co., Ltd. Company Information
  117. 8.20.2 Wuxi Cima Science Co., Ltd. Business Overview
  118. 8.20.3 Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Wuxi Cima Science Co., Ltd. Nootropic Food Ingredients Product Portfolio
  120. 8.20.5 Wuxi Cima Science Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nootropic Food Ingredients Value Chain Analysis
  2. 9.1.1 Nootropic Food Ingredients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nootropic Food Ingredients Production Mode & Process
  6. 9.2 Nootropic Food Ingredients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nootropic Food Ingredients Distributors
  9. 9.2.3 Nootropic Food Ingredients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst